These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18330521)

  • 1. Treatment of type 2 diabetes: a structured management plan.
    Baxter M
    Adv Ther; 2008 Feb; 25(2):106-14. PubMed ID: 18330521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management.
    Del Prato S; Felton AM; Munro N; Nesto R; Zimmet P; Zinman B;
    Int J Clin Pract Suppl; 2007 Dec; (157):47-57. PubMed ID: 18087796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes--treat early, treat intensively.
    Goldstein BJ; Gomis R; Lee HK; Leiter LA;
    Int J Clin Pract Suppl; 2007 Dec; (157):16-21. PubMed ID: 17991187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in diabetes management.
    Harris M
    Aust Fam Physician; 2008 Sep; 37(9):716-20. PubMed ID: 18797529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. We have the evidence, we need to act to improve diabetes care.
    Del Prato S; Horton E; Nesto R;
    Int J Clin Pract Suppl; 2007 Dec; (157):9-15. PubMed ID: 17991186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.
    Mosnier-Pudar H; Hochberg G; Eschwege E; Virally ML; Halimi S; Guillausseau PJ; Peixoto O; Touboul C; Dubois C; Dejager S
    Diabetes Metab; 2009 Jun; 35(3):220-7. PubMed ID: 19303338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
    Crasto W; Jarvis J; Khunti K; Davies MJ
    Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes].
    Shimizu T; Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Nihon Rinsho; 2012 May; 70 Suppl 3():591-601. PubMed ID: 22768584
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing disease management programs for type 2 diabetes in Germany.
    Nagel H; Baehring T; Scherbaum WA
    Manag Care; 2006 Nov; 15(11):50-3. PubMed ID: 17168071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.